long half-life and large variability [Regulatives / Guidelines]

posted by Achievwin – US, 2020-08-12 13:22 (70 d 22:49 ago) – Posting: # 21864
Views: 531

Welcome to the home of funky and funny pharmacokinetics where "Garbage in Gospel out" is day of life.

1. allowing long washout periods have seen studies with 4 -5 months washout.
2. other choice we can imagine is Two stage adaptive study design and including ANCOA in place of ANOVA...

want to know what other experts think?

» In short:
  • pretty long half-life
  • huge total variablity (i.e. within + between variability)
  • total variability is expected to be explained to some degree by some covariates

Complete thread:

Activity
 Admin contact
21,176 posts in 4,413 threads, 1,475 registered users;
online 16 (0 registered, 16 guests [including 2 identified bots]).
Forum time: Thursday 12:12 UTC (Europe/Vienna)

It is not so much that I have confidence in scientists being right,
but that I have so much in nonscientists being wrong.    Isaac Asimov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5